John Lu
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- Reproductive Medicine top 2%
Papers in
-
- Extracellular vesicles in disease 2
- Fibroblast Growth Factor Research 2
-
- Growth Hormone and Insulin-like Growth Factors 3
- Co-authors
- David L. Lacey (2 shared papers)David R. Meldrum (2 shared papers)Robert Rosenfeld (1 shared paper)Thomas C. Boone (1 shared paper)Xiaolan Zhou (1 shared paper)Qingsheng Jiao (1 shared paper)H.Q. Han (1 shared paper)Yanping Song (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (2 papers)Molecular and Cellular Biology (2 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)Nature (2 papers)Cell stem cell (1 paper)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
John Lu
27 papers receiving 3.3k citations
John Lu's Hit Papers
Peers
Comparison fields: 5 of 132
- Infectious Diseases 599
- Reproductive Medicine 246
- Structural Biology 42
- Otorhinolaryngology 110
- Oncology 577
Countries citing papers authored by John Lu
This map shows the geographic impact of John Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lu more than expected).
Fields of papers citing papers by John Lu
This network shows the impact of papers produced by John Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lu. The network helps show where John Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside John Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Structures and distributions of SARS-CoV-2 spike proteins on intact virions Hit paper breakdown → | 2020 | 780 |
| 2 | Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival Hit paper breakdown → | 2010 | 760 |
| 3 | 1986 | 406 | |
| 4 | 2000 | 344 | |
| 5 | 1982 | 201 | |
| 6 | 2006 | 136 | |
| 7 | 2006 | 126 | |
| 8 | 2009 | 122 | |
| 9 | 2009 | 114 | |
| 10 | 1991 | 113 | |
| 11 | 1990 | 93 | |
| 12 | 2023 | 34 | |
| 13 | Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma. | 2007 | 30 |
| 14 | 2013 | 29 | |
| 15 | 1988 | 27 | |
| 16 | 2008 | 26 | |
| 17 | 2010 | 22 | |
| 18 | 2019 | 20 | |
| 19 | 2003 | 18 | |
| 20 | 2010 | 17 |
About John Lu
John Lu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 27 papers that have together received 3.5k indexed citations. Recurring topics across this work include Oral health in cancer treatment (4 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Endometriosis Research and Treatment (2 papers), Extracellular vesicles in disease (2 papers), Fibroblast Growth Factor Research (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Mesenchymal stem cell research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Infectious Diseases (599 citations), Reproductive Medicine (246 citations), Structural Biology (42 citations), Otorhinolaryngology (110 citations) and Oncology (577 citations). John Lu has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include David L. Lacey, David R. Meldrum, Robert Rosenfeld, Thomas C. Boone, Xiaolan Zhou, Qingsheng Jiao, H.Q. Han, Yanping Song, Alfred L. Goldberg and Qing Chen. Their work appears in journals such as Molecular Cancer Therapeutics, Molecular and Cellular Biology, The Journal of Clinical Endocrinology & Metabolism, Nature and Cell stem cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.